Preliminary Phytochemical Screening, Acute Oral Toxicity and Anticonvulsant Activity of the Berries of Solanum nigrum Linn
Abstract
Purpose: To investigate the preliminary phytochemical properties, acute oral toxicity and anticonvulsant activity of the berries of Solanum nigrum Linn (S. nigrum)
Methods: Phytochemicals from the ethanol berry extract were screened by standard methods. Acute oral toxicity study was conducted as per Organisation for Economic Co-operation and Development (OECD) 425 guidelines while anticonvulsant activity was evaluated against pentylenetetrazole (PTZ)- induced seizure in mice. The effect of the extract at dose levels of 50, 100, 200 and 300 mg/kg body weight was evaluated in an experimental mice model, using phenobarbital as positive control (100 mg/kg p.o).
Results: Phytochemical screening revealed that the berries of S. nigrum contain carbohydrates, flavonoids, saponins, tannins, alkaloids, phenols and steroids. The oral median lethal dose of the extract was 3129 mg/kg body weight. The extract significantly delayed the latency of convulsion (p ˂ 0.05) in PTZ-induced seizure mice in at the dose of 300 mg/kg p.o. The extract also reduced the frequency of convulsion and provided up to 100 % protection (300 mg/kg p.o) against death.
Conclusion: The results obtained in this study suggest that the ethanol berry extract of Solanum nigrum is safe and possesses anticonvulsant activity in PTZ-induced seizure in mice.
Keywords: Solanum nigrum, Phytochemical, Anticonvulsant, Pentylenetetrazole, Lethal dose, Acutetoxicity
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
